David Hosfield

Follow

Person

Chicago, IL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Modulators of resistant androgen receptor
- Patent number 11,739,069
- Issue date Aug 29, 2023
- Memorial Sloan Kettering Cancer Center
- Minna D. Balbas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of resistant androgen receptor
- Patent number 10,450,294
- Issue date Oct 22, 2019
- Memorial Sloan Kettering Cancer Center
- Minna D. Balbas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of resistant androgen receptor
- Patent number 9,650,359
- Issue date May 16, 2017
- Memorial Sloan Kettering Cancer Center
- Minna D. Balbas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of resistant androgen receptor
- Patent number 9,365,542
- Issue date Jun 14, 2016
- Memorial Sloan Kettering Cancer Center
- Minna D. Balbas
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ESTROGEN RECEPTOR ALPHA ANTAGONISTS AND USES THEREOF
- Publication number 20240150294
- Publication date May 9, 2024
- The University of Chicago
- Sean W. Fanning
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF RESISTANT ANDROGEN RECEPTOR
- Publication number 20200172504
- Publication date Jun 4, 2020
- Memorial Sloan-Kettering Cancer Center
- Minna D. Balbas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF RESISTANT ANDROGEN RECEPTOR
- Publication number 20170320849
- Publication date Nov 9, 2017
- Memorial Sloan-Kettering Cancer Center
- Minna D. Balbas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF RESISTANT ANDROGEN RECEPTOR
- Publication number 20160257666
- Publication date Sep 8, 2016
- Memorial Sloan-Kettering Cancer Center
- Minna D. Balbas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF RESISTANT ANDROGEN RECEPTOR
- Publication number 20150274693
- Publication date Oct 1, 2015
- Memorial Sloan-Kettering Cancer Center
- Minna D. Balbas
- C07 - ORGANIC CHEMISTRY